Global demographic and technological shifts constantly create opportunities for innovation in the healthcare sector. 

Inflexion helps cutting-edge niche market leaders as they scale their operations. Our dedicated team includes specialist investors, healthcare entrepreneurs, and former practitioners. All investments benefit from our Healthcare Advisory Board, an international group of industry-leading experts. 
€1bn

invested

5

key sub-sectors

Sub-sectors of focus

Decorative image.

Businesses providing superior specialist services to large life sciences and pharma clients.

Contract development and manufacturing organisations developing and distributing single use consumable devices.

Niche pharma pioneers requiring capital and expertise to accelerate scale into the global market.

Specialist software, data and analytics firms providing valuable insights in their niches.

Supporting the demographic shift towards animal care, drawing on increasing knowledge and digital transformation.

Decorative image.

Our Healthcare businesses

Decorative image.
Healthcare

TPP

Veterinary platform

Decorative image.
Healthcare

Village Vets

Veterinary services

Decorative image.
Healthcare

Proteros

Drug discovery research platform

Decorative image.
Healthcare

SteriPack

Medical device CMDO

Decorative image.
Healthcare

Upperton Pharma

Pharmaceutical particle engineering

CNX Therapeutics Logo
Healthcare

CNX Therapeutics

Pharmaceuticals

Decorative image.
Healthcare

Rosemont Pharmaceuticals

Liquid pharmaceuticals

Decorative image.
Healthcare

Pharmaspectra

Medical affairs data

Decorative image.
Healthcare

European LifeCare

Vaccination Services

Decorative image.
Healthcare

Lintbells

Nutritional supplements for pets

Decorative image.
Healthcare

Medivet

Veterinary services

Decorative image.
Healthcare

Phlexglobal

Clinical research documentation

Decorative image.
Healthcare

ICS

Temporary staffing solutions

Decorative image.
Healthcare

HKI

Healthcare information services

Healthcare  specialists

/people/andrew-neville/
Decorative image.

Andrew Neville

Partner

/people/sander-ruijter/
Decorative image.

Sander Ruijter

Partner, Head of Benelux

/people/henrik-nordman/
Decorative image.

Henrik Nordman

Partner, Head of Nordics

/people/martin-preuss/
Decorative image.

Martin Preuss

Partner, Head of DACH

/people/christian-fellowes/
Decorative image.

Christian Fellowes

Investment Director

/people/robin-senivassen/
Decorative image.

Robin Senivassen

Investment Director

/people/ravi-shah/
Decorative image.

Ravi Shah

Investment Director

/people/petter-svensson/
Decorative image.

Petter Svensson

Investment Director

/people/andrea-johnson/
Decorative image.

Andrea Johnson

Assistant Director

/people/henry-awit/
Decorative image.

Henry Awit

Assistant Director

/people/martin-thrane-pedersen/
Decorative image.

Martin Thrane Pedersen

Assistant Director

/people/olivia-craig/
Decorative image.

Olivia Craig

Assistant Director

/people/louise-snoy/
Decorative image.

Louise Snoy

Investment Executive

/people/tushaar-nadkarni/
Decorative image.

Tushaar Nadkarni

Investment Executive

/people/jacqueline-phillips/
Decorative image.

Jacqueline Phillips

Investment Executive

/people/vincent-wilhelm/
Decorative image.

Vincent Wilhelm

Investment Executive

/people/emilie-le-querec/
Decorative image.

Emilie Le Querec

Origination Analyst

Latest Healthcare  activity

Decorative image.
Insights

How mid-market medical device makers can compete

Decorative image.
Insights

Setting up healthcare units for success

Decorative image.
Insights

AI-powered intelligence: GlobalData Healthcare

Decorative image.
Events

Inflexion's Medical Devices dinner

Decorative image.
Insights

Healthcare Spotlight: Clinical trials in pharma

Decorative image.
Insights

Spotlight: Establishing a US presence

Decorative image.
Events

Inflexion's Life Sciences dinner in Barcelona

Inflexion’s trust in the management team and vision allowed us to push forward faster than we had anticipated. With their support, we accelerated recruitment ahead of plan and invested in significant manufacturing process improvements.

Nikki Whitfield

CEO, Upperton Pharma Solutions

Inflexion genuinely understood that they were minority backers. My job as Chair was to bring in their expertise when I felt it was needed. They genuinely brought real expertise and a strong will to support the plan once it was decided.

Deirdre Burns

Chair, TPP

We knew what needed to happen, it was just being given the playing field to actually bring it to life, and the Inflexion relationship has allowed us to do that.

Howard Taylor

CEO, Rosemont Pharmaceuticals
CASE STUDY

Rapidly scaling Upperton’s manufacturing capabilities

Find out how Upperton doubled headcount and expanded its scale within 18 months of partnering with Inflexion, with investment for a new purpose-built facility which increased manufacturing space 10x.
Find out more